Catalent Supports Eli Lilly's Clinical Trial Supply Needs with New Investment - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Catalent Supports Eli Lilly's Clinical Trial Supply Needs with New Investment

Source: Applied Clinical Trials

Catalent, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, announced that in support of the growth of its strategic partner, Eli Lilly, it is to install new automated prefilled syringe clinical packaging lines at its Philadelphia Clinical Supply Center of Excellence.

Catalent already has automated prefilled syringe packaging capabilities in its clinical supply facility in Schorndorf, Germany, providing end-to-end clinical supply solutions from clinical supply management, comparator sourcing and primary packaging to storage and distribution globally. The packaging line is capable of the fully automated insertion of plunger rods, application of randomized and non-randomized labels and back-stop clips, and off-line labeling with booklet labels.

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here